Product Description: BSH-IN-1 is a potent and covalent inhibitor of gut bacterial recombinant bile salt hydrolases (BSHs) with IC50s of 108 nM and 427 nM for B. longum BSH (Gram positive) and B. theta BSH (Gram negative), respectively[1].
Applications: COVID-19-immunoregulation
Formula: C25H41FO3
References: [1]Adhikari AA, et al. Development of a covalent inhibitor of gut bacterial bile salt hydrolases.Nat Chem Biol. 2020 Mar;16(3):318-326.
CAS Number: 2553217-91-5
Molecular Weight: 408.59
Compound Purity: 99.08
Research Area: Infection
Solubility: DMSO : 25 mg/mL (ultrasonic;warming;heat to 80°C)